Teva Pharmaceutical Industries Ltd. (TEVA) - Financials, balance sheet (quarterly)

6,053 ILA

104

1.75%

Last update May 25, 3:49 PM IDT

Market closed

Day range

6,053

6,036

6,097

Previous close

5,949

Open

6,038

Access this stock data via API

Teva Pharmaceutical Industries Ltd.

6,053.00

104

1.75%

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	38.4B	39.3B	41.8B	41.3B
Current assets	11.5B	12.6B	12.3B	11.6B
Cash	529M	1.3B	1.5B	1.2B
Cash equivalents	1.2B	2.0B	1.8B	1.1B
Cash and cash equivalents	1.7B	3.3B	3.3B	2.3B
Other short term investments	—	—	—	—
Accounts receivable	3.4B	3.1B	3.5B	3.8B
Other receivables	—	—	—	—
Inventory	3.2B	3.0B	4.0B	3.9B
Prepaid assets	1.0B	1.0B	1.1B	1.1B
Restricted cash	—	—	—	—
Assets held for sale	1.8B	1.8B	2M	69M
Hedging assets	—	—	—	—
Other current assets	368M	409M	445M	516M
Non current assets	26.9B	26.8B	29.4B	29.7B
Properties	5.0B	367M	6.0B	5.9B
Land and improvements	—	213M	—	—
Machinery furniture equipment	—	5.5B	—	—
Construction in progress	—	1.3B	—	—
Leases	—	—	—	—
Accumulated depreciation	—	-4.4B	—	—
Goodwill	35.1B	34.7B	37.0B	37.8B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	4.2B	4.4B	4.8B	4.9B
Investments and advances	—	—	—	—
Other non current assets	2.2B	2.3B	2.5B	2.4B
Total liabilities	32.1B	33.6B	35.4B	34.8B
Current liabilities	11.2B	12.8B	13.8B	13.0B
Accounts payable	2.3B	2.2B	2.4B	2.4B
Accrued expenses	3.0B	2.8B	3.0B	2.8B
Short term debt	421M	1.8B	2.6B	2.1B
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	474M	624M	619M	492M
Other current liabilities	1.3B	1.7B	1.5B	1.5B
Non current liabilities	21.0B	20.8B	21.6B	21.7B
Long term provisions	—	—	—	—
Long term debt	16.5B	16.3B	16.7B	16.8B
Provision for risks and charges	—	—	—	—
Deferred liabilities	461M	483M	538M	553M
Derivative product liabilities	—	—	—	—
Other non current liabilities	4.0B	4.0B	4.3B	4.4B
Shareholders equity
Common stock	58M	58M	58M	58M
Retained earnings	-15.0B	-15.2B	-15.0B	-14.5B
Other shareholders equity	-2.7B	-3.1B	-2.8B	-2.9B
Total shareholders equity	6.3B	5.7B	6.4B	6.6B
Additional paid in capital	28.0B	27.8B	27.9B	27.8B
Treasury stock	4.1B	4.1B	4.1B	4.1B
Minority interest	7M	347M	319M	204M